UniProt ID | NRBP_HUMAN | |
---|---|---|
UniProt AC | Q9UHY1 | |
Protein Name | Nuclear receptor-binding protein | |
Gene Name | NRBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 535 | |
Subcellular Localization | Cytoplasm, cell cortex . Endomembrane system . Cell projection, lamellipodium . Colocalizes with activated RAC3 to endomembranes and at the cell periphery in lamellipodia. | |
Protein Description | May play a role in subcellular trafficking between the endoplasmic reticulum and Golgi apparatus through interactions with the Rho-type GTPases. Binding to the NS3 protein of dengue virus type 2 appears to subvert this activity into the alteration of the intracellular membrane structure associated with flaviviral replication.. | |
Protein Sequence | MSEGESQTVLSSGSDPKVESSSSAPGLTSVSPPVTSTTSAASPEEEEESEDESEILEESPCGRWQKRREEVNQRNVPGIDSAYLAMDTEEGVEVVWNEVQFSERKNYKLQEEKVRAVFDNLIQLEHLNIVKFHKYWADIKENKARVIFITEYMSSGSLKQFLKKTKKNHKTMNEKAWKRWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDTINNHVKTCREEQKNLHFFAPEYGEVTNVTTAVDIYSFGMCALEMAVLEIQGNGESSYVPQEAISSAIQLLEDPLQREFIQKCLQSEPARRPTARELLFHPALFEVPSLKLLAAHCIVGHQHMIPENALEEITKNMDTSAVLAEIPAGPGREPVQTLYSQSPALELDKFLEDVRNGIYPLTAFGLPRPQQPQQEEVTSPVVPPSVKTPTPEPAEVETRKVVLMQCNIESVEEGVKHHLTLLLKLEDKLNRHLSCDLMPNENIPELAAELVQLGFISEADQSRLTSLLEETLNKFNFARNSTLNSAAVTVSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSEGESQTV ------CCCCCCCEE | 55.07 | 19413330 | |
2 | Phosphorylation | ------MSEGESQTV ------CCCCCCCEE | 55.07 | 29255136 | |
6 | Phosphorylation | --MSEGESQTVLSSG --CCCCCCCEECCCC | 41.84 | 22167270 | |
8 | Phosphorylation | MSEGESQTVLSSGSD CCCCCCCEECCCCCC | 32.47 | 22167270 | |
11 | Phosphorylation | GESQTVLSSGSDPKV CCCCEECCCCCCCCC | 28.46 | 29255136 | |
12 | Phosphorylation | ESQTVLSSGSDPKVE CCCEECCCCCCCCCC | 37.85 | 29255136 | |
14 | Phosphorylation | QTVLSSGSDPKVESS CEECCCCCCCCCCCC | 53.33 | 29255136 | |
20 | Phosphorylation | GSDPKVESSSSAPGL CCCCCCCCCCCCCCC | 38.21 | 20873877 | |
21 | Phosphorylation | SDPKVESSSSAPGLT CCCCCCCCCCCCCCC | 18.14 | 27251275 | |
22 | Phosphorylation | DPKVESSSSAPGLTS CCCCCCCCCCCCCCC | 39.54 | 27251275 | |
23 | Phosphorylation | PKVESSSSAPGLTSV CCCCCCCCCCCCCCC | 40.19 | 27251275 | |
28 | Phosphorylation | SSSAPGLTSVSPPVT CCCCCCCCCCCCCCC | 32.75 | 20873877 | |
29 | Phosphorylation | SSAPGLTSVSPPVTS CCCCCCCCCCCCCCC | 26.16 | 20873877 | |
31 | Phosphorylation | APGLTSVSPPVTSTT CCCCCCCCCCCCCCC | 24.21 | 30576142 | |
35 | Phosphorylation | TSVSPPVTSTTSAAS CCCCCCCCCCCCCCC | 26.57 | 20873877 | |
36 | Phosphorylation | SVSPPVTSTTSAASP CCCCCCCCCCCCCCH | 29.89 | 20873877 | |
37 | Phosphorylation | VSPPVTSTTSAASPE CCCCCCCCCCCCCHH | 18.53 | 20873877 | |
38 | Phosphorylation | SPPVTSTTSAASPEE CCCCCCCCCCCCHHH | 19.01 | 30576142 | |
39 | Phosphorylation | PPVTSTTSAASPEEE CCCCCCCCCCCHHHH | 23.17 | 20873877 | |
42 | Phosphorylation | TSTTSAASPEEEEES CCCCCCCCHHHHCCC | 32.34 | 30576142 | |
49 | Phosphorylation | SPEEEEESEDESEIL CHHHHCCCCCHHHHH | 54.34 | 26657352 | |
53 | Phosphorylation | EEESEDESEILEESP HCCCCCHHHHHHHCC | 42.11 | 30576142 | |
59 | Phosphorylation | ESEILEESPCGRWQK HHHHHHHCCCCHHHH | 19.00 | 27251275 | |
134 | Ubiquitination | LNIVKFHKYWADIKE CCHHEEHHHHHHHHH | 45.69 | 19608861 | |
134 | Acetylation | LNIVKFHKYWADIKE CCHHEEHHHHHHHHH | 45.69 | 19608861 | |
150 | Phosphorylation | KARVIFITEYMSSGS CCEEEEEEEECCCCC | 15.43 | 23663014 | |
152 | Phosphorylation | RVIFITEYMSSGSLK EEEEEEEECCCCCHH | 8.14 | 23663014 | |
154 | Phosphorylation | IFITEYMSSGSLKQF EEEEEECCCCCHHHH | 30.55 | 23663014 | |
155 | Phosphorylation | FITEYMSSGSLKQFL EEEEECCCCCHHHHH | 18.83 | 23663014 | |
157 | Phosphorylation | TEYMSSGSLKQFLKK EEECCCCCHHHHHHH | 34.05 | 23663014 | |
220 | Phosphorylation | NGLIKIGSVAPDTIN CCEEEECCCCCHHHH | 20.69 | 28857561 | |
225 | Phosphorylation | IGSVAPDTINNHVKT ECCCCCHHHHHHHHH | 25.25 | 23403867 | |
231 | Ubiquitination | DTINNHVKTCREEQK HHHHHHHHHHHHHHC | 34.06 | - | |
232 | Phosphorylation | TINNHVKTCREEQKN HHHHHHHHHHHHHCC | 18.73 | 25849741 | |
306 | Ubiquitination | LQREFIQKCLQSEPA HHHHHHHHHHCCCCC | 31.90 | - | |
362 | Phosphorylation | EITKNMDTSAVLAEI HHHHCCCCCCEEEEC | 14.07 | 25627689 | |
363 | Phosphorylation | ITKNMDTSAVLAEIP HHHCCCCCCEEEECC | 16.47 | 21815630 | |
380 | Phosphorylation | PGREPVQTLYSQSPA CCCCCHHHHHCCCCC | 28.09 | 27732954 | |
383 | Phosphorylation | EPVQTLYSQSPALEL CCHHHHHCCCCCHHH | 27.56 | 27732954 | |
385 | Phosphorylation | VQTLYSQSPALELDK HHHHHCCCCCHHHHH | 13.24 | 27732954 | |
392 | Ubiquitination | SPALELDKFLEDVRN CCCHHHHHHHHHHHC | 65.55 | - | |
402 | Phosphorylation | EDVRNGIYPLTAFGL HHHHCCCCCHHHCCC | 8.12 | 26074081 | |
405 | Phosphorylation | RNGIYPLTAFGLPRP HCCCCCHHHCCCCCC | 18.55 | 26074081 | |
421 | Phosphorylation | QPQQEEVTSPVVPPS CCCCCCCCCCCCCCC | 30.50 | 29255136 | |
422 | Phosphorylation | PQQEEVTSPVVPPSV CCCCCCCCCCCCCCC | 22.37 | 29255136 | |
428 | Phosphorylation | TSPVVPPSVKTPTPE CCCCCCCCCCCCCCC | 30.12 | 28348404 | |
430 | Ubiquitination | PVVPPSVKTPTPEPA CCCCCCCCCCCCCCC | 53.80 | - | |
431 | Phosphorylation | VVPPSVKTPTPEPAE CCCCCCCCCCCCCCC | 30.18 | 19664994 | |
433 | Phosphorylation | PPSVKTPTPEPAEVE CCCCCCCCCCCCCCC | 45.58 | 19664994 | |
441 | Phosphorylation | PEPAEVETRKVVLMQ CCCCCCCCCEEEEEE | 40.75 | 23927012 | |
471 | Ubiquitination | LLLKLEDKLNRHLSC HHHHHHHHHHHHCCC | 37.98 | - | |
505 | O-linked_Glycosylation | FISEADQSRLTSLLE CCCHHHHHHHHHHHH | 29.79 | 30059200 | |
517 | Ubiquitination | LLEETLNKFNFARNS HHHHHHHHHCHHCCC | 44.81 | 21890473 | |
532 | O-linked_Glycosylation | TLNSAAVTVSS---- CCCCCEEECCC---- | 15.22 | 30059200 | |
534 | O-linked_Glycosylation | NSAAVTVSS------ CCCEEECCC------ | 22.44 | 30059200 | |
534 | Phosphorylation | NSAAVTVSS------ CCCEEECCC------ | 22.44 | 25159151 | |
535 | O-linked_Glycosylation | SAAVTVSS------- CCEEECCC------- | 39.65 | 30059200 | |
535 | Phosphorylation | SAAVTVSS------- CCEEECCC------- | 39.65 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NRBP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NRBP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NRBP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
T22D4_HUMAN | TSC22D4 | physical | 16189514 | |
LRIF1_HUMAN | LRIF1 | physical | 16169070 | |
ELOB_HUMAN | TCEB2 | physical | 18187417 | |
ELOC_HUMAN | TCEB1 | physical | 18187417 | |
CSN5_HUMAN | COPS5 | physical | 17052710 | |
SART3_HUMAN | SART3 | physical | 22863883 | |
T22D4_HUMAN | TSC22D4 | physical | 25416956 | |
T22D4_HUMAN | TSC22D4 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-134, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-431 AND THR-433,AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-433, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-433, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-433, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-433, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-431 AND THR-433, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-433, AND MASSSPECTROMETRY. |